Literature DB >> 10444479

Myocardial tumor necrosis factor-alpha secretion in hypertensive and heart failure-prone rats.

M R Bergman1, R H Kao, S A McCune, B J Holycross.   

Abstract

Acute increases in blood pressure (BP) increase myocardial tumor necrosis factor (TNF)-alpha production, but it is not known whether chronic hypertensive stress elevates myocardial TNF-alpha production, possibly contributing to cardiac remodeling, decreased cardiac function, and faster progression to heart failure. BP, cardiac function, and size were evaluated in normotensive [Sprague-Dawley (SD)], spontaneously hypertensive (SHR), and spontaneously hypertensive heart failure-prone (SHHF) rats at 6, 12, 15, and 18 mo of age and in failing SHHF. Left ventricular tissues were evaluated for secretion of bioactive TNF-alpha and inhibition of TNF-alpha secretion by phosphodiesterase inhibitors. All ventricles secreted bioactive and immunoreactive TNF-alpha, but secretion decreased with age. SHR and SHHF rats secreted more TNF-alpha than SD rats at 6 mo of age, but only failing SHHF rats secreted significantly more TNF-alpha at 18 mo. Amrinone inhibited TNF-alpha secretion in all rats and was less potent but more efficacious than RO-201724 in all strains. TNF-alpha secretion correlated with BP and left ventricular mass in 6-mo-old rats, but this relationship disappeared with age. Results suggest that hypertension and/or cardiac remodeling is associated with elevated myocardial TNF-alpha, and, although hypertension, per se, did not maintain elevated cardiac TNF-alpha levels, SHHF rats increase TNF-alpha production during the end stages of failure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10444479     DOI: 10.1152/ajpheart.1999.277.2.H543

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation.

Authors:  Xavier Palomer; M Silvia Román-Azcona; Javier Pizarro-Delgado; Ana Planavila; Francesc Villarroya; Brenda Valenzuela-Alcaraz; Fátima Crispi; Álvaro Sepúlveda-Martínez; Irene Miguel-Escalada; Jorge Ferrer; J Francisco Nistal; Raquel García; Mercy M Davidson; Emma Barroso; Manuel Vázquez-Carrera
Journal:  Signal Transduct Target Ther       Date:  2020-02-28

2.  Downregulation of adenine nucleotide translocator 1 exacerbates tumor necrosis factor-α-mediated cardiac inflammatory responses.

Authors:  Shi Pan; Nadan Wang; Sara Bisetto; Bing Yi; Shey-Shing Sheu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-11-07       Impact factor: 4.733

3.  Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease.

Authors:  Jan Monti; Judith Fischer; Svetlana Paskas; Matthias Heinig; Herbert Schulz; Claudia Gösele; Arnd Heuser; Robert Fischer; Cosima Schmidt; Alexander Schirdewan; Volkmar Gross; Oliver Hummel; Henrike Maatz; Giannino Patone; Kathrin Saar; Martin Vingron; Steven M Weldon; Klaus Lindpaintner; Bruce D Hammock; Klaus Rohde; Rainer Dietz; Stuart A Cook; Wolf-Hagen Schunck; Friedrich C Luft; Norbert Hubner
Journal:  Nat Genet       Date:  2008-05       Impact factor: 38.330

4.  Effect of salvia miltiorrhiza Bge on left ventricular hypertrophy and the expression of tumor necrosis factor-alpha in spontaneously hypertensive rats.

Authors:  Lianping Sun; Zhi Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-06

5.  The interplay between NF-kappaB and E2F1 coordinately regulates inflammation and metabolism in human cardiac cells.

Authors:  Xavier Palomer; David Álvarez-Guardia; Mercy M Davidson; Tung O Chan; Arthur M Feldman; Manuel Vázquez-Carrera
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

6.  miR-146a targets Fos expression in human cardiac cells.

Authors:  Xavier Palomer; Eva Capdevila-Busquets; Gaia Botteri; Mercy M Davidson; Cristina Rodríguez; José Martínez-González; Francisco Vidal; Emma Barroso; Tung O Chan; Arthur M Feldman; Manuel Vázquez-Carrera
Journal:  Dis Model Mech       Date:  2015-06-25       Impact factor: 5.758

Review 7.  Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers.

Authors:  Colleen M Dewey; Kathryn M Spitler; Jessica M Ponce; Duane D Hall; Chad E Grueter
Journal:  J Am Heart Assoc       Date:  2016-05-31       Impact factor: 5.501

Review 8.  Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.

Authors:  Lili Wang; Rufeng Ma; Chenyue Liu; Haixia Liu; Ruyuan Zhu; Shuzhen Guo; Minke Tang; Yu Li; Jianzhao Niu; Min Fu; Sihua Gao; Dongwei Zhang
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 9.  Immunometabolic cross-talk in the inflamed heart.

Authors:  Federica M Marelli-Berg; Dunja Aksentijevic
Journal:  Cell Stress       Date:  2019-06-07

10.  SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation.

Authors:  Xavier Palomer; M Silvia Román-Azcona; Javier Pizarro-Delgado; Ana Planavila; Francesc Villarroya; Brenda Valenzuela-Alcaraz; Fátima Crispi; Álvaro Sepúlveda-Martínez; Irene Miguel-Escalada; Jorge Ferrer; J Francisco Nistal; Raquel García; Mercy M Davidson; Emma Barroso; Manuel Vázquez-Carrera
Journal:  Signal Transduct Target Ther       Date:  2020-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.